A dynamic modelling approach to North-South disparities in IPR protection
Oxford Economic Papers · 01.01.2026 · 78 (1) · 132-156
DOI: 10.1093/oep/gpaf024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oxford Economic Papers, online erschienen am 25.09.2025. Verfasst von Hwan C Lin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: UNCC Belk College of Business.
Abstract (Originalsprache)
This article introduces a dynamic modelling approach to tackling North-South protection of intellectual property rights (IPRs) in a global general-equilibrium environment, where bidirectional R&D, region-specific needs, and creative destruction interact to give rise to an analytical challenge. A complicated dynamical system is solved numerically for policy experiments with the South strengthening IPRs to match the Northern standard. Surprisingly, the South can reap a net gain, but the North cannot, if the welfare metric takes into account each region’s dynamic transition to steady state. Yet, if the transition dynamics are ignored, such a North-South welfare scenario could be reversed. More surprisingly, the no-winner scenario may even emerge if innovation can cause creative destruction significantly. The article thus cautions against previous studies that neglect the general-equilibrium dynamics driven by the elements of bidirectional R&D, region-specific needs, and creative destruction.
Förderung
- UNCC Belk College of Business
Zitieren
APA
Lin, H. C. (2026). A dynamic modelling approach to North-South disparities in IPR protection. Oxford Economic Papers, 78(1), 132-156. https://doi.org/10.1093/oep/gpaf024
Vancouver
Lin HC. A dynamic modelling approach to North-South disparities in IPR protection. Oxford Economic Papers. 2026;78(1):132-156. doi:10.1093/oep/gpaf024
BibTeX
@article{Lin2026,
author = {Lin, Hwan C},
title = {A dynamic modelling approach to North-South disparities in IPR protection},
journal = {Oxford Economic Papers},
year = {2026},
volume = {78},
number = {1},
pages = {132--156},
doi = {10.1093/oep/gpaf024}
}
EUVIMED